Catalyst Wire Dossier Catalyst Wire Dossier

AMG 334 Injection

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 334 Injection, covering 2022-02-18 to 2022-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies [Phase 3]

See pricing